ZOSANO PHARMA CORPORATION 51,250,000 Shares of Common Stock and Series F Warrants to Purchase 51,250,000 Shares of Common Stock (par value $0.0001 per share) Underwriting AgreementZosano Pharma • February 9th, 2022 • Zosano Pharma Corp • Pharmaceutical preparations • New York
Zosano Pharma Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to Maxim Group LLC (the “Underwriter”) (i) an aggregate of 51,250,000 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”) and (ii) Series F Warrants of the Company, in the form set forth in Exhibit B hereto, to purchase shares of Common Stock (the “Warrants”). Each Share is being sold together with one Warrant; and each full Warrant is exercisable for one Share at an exercise price of $0.30 per whole share. The 51,250,000 Shares and 51,250,000 Warrants to be sold by the Company are referred to as the “Firm Securities.” In addition, the Company has granted to the Underwriter an option to purchase up to an additional 7,687,500 Shares (together with the Shares, the “Offered Shares”) and 7,687,500 Warrants as provided in Section 2. The additional 7,687,500 Shares and 7,687,500 Warrants to be sold by the Company pursuant to such option are collectively called
ZOSANO PHARMA CORPORATION UP TO $15,000,000 OF COMMON STOCK (par value $0.0001 per share) AT-THE-MARKET SALES AGREEMENTZosano Pharma • August 19th, 2019 • Zosano Pharma Corp • Pharmaceutical preparations • New York
Zosano Pharma Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows:
ZOSANO PHARMA CORPORATION NONSTATUTORY STOCK OPTION AWARD AGREEMENTZosano Pharma • March 12th, 2021 • Zosano Pharma Corp • Pharmaceutical preparations • Delaware
Zosano Pharma Corporation (the “Company”) hereby grants to [ ] (the “Holder”) an option (the “Option”) to purchase a total of [ ] shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at the price and on the terms set forth in this Zosano Pharma Corporation Nonstatutory Stock Option Award Agreement (the “Award Agreement”).
ZOSANO PHARMA CORPORATION NONSTATUTORY STOCK OPTION AWARD AGREEMENTZosano Pharma • June 5th, 2017 • Zosano Pharma Corp • Pharmaceutical preparations • Delaware
Zosano Pharma Corporation (the “Company”), hereby grants to [name] (the “Holder”) an option (the “Option”) to purchase a total of [number] shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at the price and on the terms set forth in this Zosano Pharma Corporation Nonstatutory Stock Option Award Agreement (the “Award Agreement”).
